Invivyd aligns with FDA advice on LIBERTY Phase III Covid-19 trial
The trial expects to enrol approximately 210 participants.
Trilink Thematic mRNA WP
Everest Medicines doses first participant in trial of EVM14 cancer vaccine
NHS England to expand trial access for head and neck cancer vaccine
Moderna’s mRNA flu shot outperforms current standard at Phase III
FDA clears CureVac’s IND application for Phase I lung cancer trial
Everest Medicines begins dosing in mRNA cancer vaccine trial
SK bioscience gains approval in Australia to begin trials of mRNA-based vaccine
Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer
